Medicare Rx Card Savings Will Be 17% For Brand Drugs, PBM Group Says
This article was originally published in The Pink Sheet Daily
Executive Summary
A Pharmaceutical Care Management Association survey of its PBM members suggests average savings of 35% for generics across retail and mail order channels.
You may also be interested in...
Manufacturers Will Not Change Medicare Rx Discount Card Prices, NACDS' Fuller Predicts
The hassle of re-negotiating, coupled with increased scrutiny of pricing practices, will discourage manufacturers from frequent price changes, Fuller says.
Bristol To Name New R&D Head Shortly
Senior VP-Global Clinical & Pharmaceutical Development Elliott Sigal is acting president of Bristol-Myers Squibb’s research institute following the death of James Palmer.
Aranesp Performance Strong Heading Into "Transition" Time, Amgen Says
The company is talking with oncologists about Aranesp ahead of a switch in Medicare reimbursement in January 2005. U.S. sales for the red blood cell product were up 32% in the third quarter.